Autophagy and Alzheimer's disease: How far science has to be progressed? - correspondence
- PMID: 36845802
- PMCID: PMC9949842
- DOI: 10.1097/MS9.0000000000000156
Autophagy and Alzheimer's disease: How far science has to be progressed? - correspondence
Conflict of interest statement
The authors declare that they have no financial conflict of interest with regard to the content of this report.
References
-
- Islam F, Nafady MH, Islam MR, et al. . Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside. Mol Neurobiol 2022;59:4384–4404. - PubMed
-
- Mitra S, Anjum J, Muni M, et al. . Exploring the journey of emodin as a potential neuroprotective agent: novel therapeutic insights with molecular mechanism of action. Biomed Pharmacother 2022;149:112877. - PubMed
-
- Zhang Z, Yang X, Song YQ, et al. . Autophagy in Alzheimer’s disease pathogenesis: therapeutic potential and future perspectives. Ageing Res Rev 2021;72:101464 - PubMed
LinkOut - more resources
Full Text Sources